Literature DB >> 7845317

Cytomegalovirus in liver biopsies of marrow transplant recipients: detection methods, clinical, histological and immunohistological features.

H Einsele1, H D Waller, P Weber, N Frickhofen, S Dette, H P Horny, A Roos, H Roos, H Hebart, H Schmidt.   

Abstract

In a retrospective analysis liver biopsy specimens obtained from 44 marrow transplant recipients were studied to evaluate the frequency of local presence of human cytomegalovirus (CMV) and graft-versus-host disease (GvHD)-like histological and immunohistological alterations in patients with and without liver dysfunction following bone marrow transplantation (BMT). In 22 of 28 patients with marked liver dysfunction after BMT and histopathological alterations described as typical for acute GvHD CMV could be detected in the liver biopsy specimen. The polymerase chain reaction (PCR) technique revealed the highest sensitivity for CMV detection in liver biopsy samples, but in 20 of 22 PCR-positive specimens CMV infection could be confirmed by at least one additional technique. All the liver biopsies obtained from 16 patients with normal liver function lacking histopathological signs of GvHD were CMV negative. In all 3 patients with CMV-positive liver biopsy started on antiviral therapy liver function improved and no generalized CMV disease occurred. All the 4 patients without local presence of CMV started on severe immunosuppressive therapy showed an improvement of liver dysfunction without occurrence of CMV infection. Local CMV infection of the liver could not be differentiated from hepatic GvHD by clinical and histopathological features, nor by immunohistological analysis of the bile duct epithelium. In contrast, only in liver biopsy with local viral presence could an increase in HLA class II- and ICAM-1 expression be demonstrated on hepatocytes. Thus, especially the high negative predictive value of the PCR technique helps to manage the patient with liver dysfunction after BMT.

Entities:  

Mesh:

Year:  1994        PMID: 7845317     DOI: 10.1007/bf00194173

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  26 in total

Review 1.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

2.  Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens.

Authors:  A Ziegler; J Heinig; C Müller; H Götz; F P Thinnes; B Uchańska-Ziegler; P Wernet
Journal:  Immunobiology       Date:  1986-03       Impact factor: 3.144

3.  Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease.

Authors:  H Einsele; G Ehninger; M Steidle; A Vallbracht; M Müller; H Schmidt; J G Saal; H D Waller; C A Müller
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

4.  A small polypeptide different from beta2-microglobin associated with a human cell surface antigen.

Authors:  A Ziegler; C Milstein
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

5.  Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants.

Authors:  G P Pawelec; S Shaw; A Ziegler; C Müller; P Wernet
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique.

Authors:  H Einsele; M Steidle; A Vallbracht; J G Saal; G Ehninger; C A Müller
Journal:  Blood       Date:  1991-03-01       Impact factor: 22.113

7.  Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas.

Authors:  H Stein; A Bonk; G Tolksdorf; K Lennert; H Rodt; J Gerdes
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

8.  Significant reduction of cytomegalovirus (CMV) disease by prophylaxis with CMV hyperimmune globulin plus oral acyclovir.

Authors:  H Einsele; A Vallbracht; M Friese; H Schmidt; M Haen; R Dopfer; D Niethammer; H D Waller; G Ehninger
Journal:  Bone Marrow Transplant       Date:  1988-11       Impact factor: 5.483

9.  Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosuppression.

Authors:  G A Müller; L Seipel; T Risler
Journal:  Klin Wochenschr       Date:  1986-03-03

10.  Cytomegalovirus infection after marrow transplantation for aplastic anemia.

Authors:  P Ljungman; D Niederwieser; M S Pepe; G Longton; R Storb; J D Meyers
Journal:  Bone Marrow Transplant       Date:  1990-11       Impact factor: 5.483

View more
  1 in total

Review 1.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.